Icrucumab (Anti-VEGFR1 / FLT1)

Icrucumab (Anti-VEGFR1 / FLT1) is a humanized Anti-VEGFR-1 IgG1 monoclonal antibody, with potential anti-tumor and anti-metastatic agent. It also act as a therapeutic anti-angiogenic agent in different pathological contexts.
Supplier Selleck Chemicals
Product # A2301
Sku # A2301-1mg*5
Pricing 1mg*5, $790.00
Feedback